(VIANEWS) – Shares of Arena Pharmaceuticals (NASDAQ Composite: ARNA) rose by a staggering 26% in 30 days from $47.04 to $59.27 at 06:18 EST on Tuesday, after four successive sessions in a row of gains. NASDAQ Composite is falling 0.07% to $15,105.58, after four sequential sessions in a row of losses.
Arena Pharmaceuticals’s last close was $60.25, 33.2% below its 52-week high of $90.19.
Today’s last reported volume for Arena Pharmaceuticals is 343861 which is 31.09% below its average volume of 499055.
The company’s growth estimates for the present quarter and the next is a negative 49.7% and a negative 15.7%, respectively.
Arena Pharmaceuticals’s Stock Yearly Top and Bottom Value
Arena Pharmaceuticals’s stock is valued at $59.27 at 06:18 EST, way below its 52-week high of $90.19 and way higher than its 52-week low of $45.50.
Arena Pharmaceuticals’s Moving Average
Arena Pharmaceuticals’s worth is higher than its 50-day moving average of $55.12 and below its 200-day moving average of $64.38.
More news about Arena Pharmaceuticals (ARNA).